The New York Stem Cell Foundation (NYSCF) held its fifth annual spring public outreach event on Thursday, March 25 at The TimesCenter in New York City. The event brought together leading stem cell scientists with patient advocates to explain the latest developments in the stem cell field with a focus on the current efforts to apply stem cell research to finding new treatments for Alzheimer's disease.
[Video] Alzheimer's Disease: How Stem Cell Research Will Make A Difference
Panelists included: Dr. Sam Gandy, Associate Director of the Mount Sinai Alzheimer's Disease Research Center, and Chairman Emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association; Greg Simon, Senior Vice President of Worldwide Policy at Pfizer; Dr. Howard Fillit, Founding Executive Director of the Institute for the Study of Aging (ISOA) and the Alzheimer's Drug Discovery Foundation (ADDF); William Haseltine, Chairman and CEO of Haseltine Associates and former Chairman and CEO of Human Genome Sciences; Dr. Kevin C. Eggan, Chief Scientific Officer of The New York Stem Cell Foundation and Assistant Professor of Stem Cell and Regenerative Medicine at The Harvard Stem Cell Institute; and Susan L. Solomon, Chief Executive Officer of The New York Stem Cell Foundation.
Ceci Connolly, Health Politics Reporter at The Washington Post, moderated the panel.